Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudomonas quasicaspiana strain:CDFA 611

ABSTRACT: Pseudomonas quasicaspiana strain:CDFA 611 Genome sequencing and assembly

PROVIDER: PRJNA723571 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR14916892.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Pseudomonas californiensis strain:CDFA 601

Project description:Pseudomonas californiensis strain:CDFA 601 Genome sequencing and assembly

| PRJNA723575 | ENA

Pseudomonas quasicaspiana strain:CDFA 553

Project description:Pseudomonas quasicaspiana strain:CDFA 553 Genome sequencing and assembly

| PRJNA723570 | ENA

Pseudomonas californiensis strain:CDFA 602

Project description:Pseudomonas californiensis strain:CDFA 602 Genome sequencing and assembly

| PRJNA723576 | ENA

Pseudomonas quasicaspiana strain:CDFA 550

Project description:Pseudomonas quasicaspiana strain:CDFA 550 Genome sequencing and assembly

| PRJNA723569 | ENA

Pseudomonas sp. CDFA 610

Project description:Pseudomonas sp. CDFA 610 Genome sequencing and assembly

| PRJNA723583 | ENA

Escherichia coli strain:611

Project description:Escherichia coli strain:611 Genome sequencing and assembly

| PRJNA1197070 | ENA

Herbaspirillum huttiense strain:611 | isolate:DPS 611

Project description:Herbaspirillum huttiense 611 genome sequencing

| PRJNA695696 | ENA

miR-611 overexpression effect on tongue cancer cells

Project description:Analysis of SCC-15 tongue cancer cells overexpressing miR-611. miR-611 is frequently upregulated in primary tongue cancer. Results provide insight into the role of miR-611 in the pathogenesis of tongue cancer. We used micorarrays to detailed the genes regulated by miR-611 in SCC-15 cells.

2019-12-01 | GSE129118 | GEO

Brucella ceti strain:27 | isolate:02/611

Project description:Brucella ceti strain:27 | isolate:02/611 Genome sequencing and assembly

| PRJNA680680 | ENA

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK

Project description:Tyrosine kinase inhibitors (TKIs) targeting Anaplastic Lymphoma Kinase (ALK) have transformed the treatment landscape of ALK fusion-positive non-small cell lung carcinoma (NSCLC), but limited options for patients who progress on approved TKIs highlight a continued need for an orthogonal therapeutic approach. TRI-611 is a potent, brain-penetrant molecular glue degrader (MGD) of ALK fusion proteins with the potential to address this need . TRI-611 promotes the proximity of the ALK kinase domain and CRBN via a unique degron interface distal from the kinase active site. The unique binding interface of TRI-611 leads to selectivity across the proteome including known CRBN neo-substrates and other kinases. TRI-611 treatment induces degradation of all forms of oncogenic ALK fusion proteins, including TKI-resistant mutated versions of ALK, leading to regression of cell line and patient-derived subcutaneous and intracranial tumour models of ALK-positive NSCLC. TRI-611 can be combined with orthosteric ALK TKIs, achieving synergistic and durable tumour regressions. TRI-611 represents the first example of a clinical stage MGD targeting an oncogenic gene fusion and has the potential to expand the arsenal of therapeutic options for ALK-positive NSCLC patients.

2026-08-01 | GSE329452 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data